BlackRock
INAB icon

BlackRock’s IN8bio INAB Stock Holding History

BlackRock’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124 Hold
84
– – ﹤0.01% 5604
2025
Q4 		$197 Hold
84
– – ﹤0.01% 5460
2025
Q3 		$182 Hold
84
– – ﹤0.01% 5390
2025
Q2 		$176 Sell
84
-1,866
-96% -$7.59K ﹤0.01% 5403
2025
Q1 		$9.71K Sell
1,950
-36
-2% -$287 ﹤0.01% 5178
2024
Q4 		$15.3K Buy
1,986
+12
+0.6% +$105 ﹤0.01% 5134
2024
Q3 		$16K Buy
1,974
+71
+4% +$1.29K ﹤0.01% 4959
2024
Q2 		$48.3K Buy
1,903
+963
+102% +$30.9K ﹤0.01% 4868
2024
Q1 		$33.3K Sell
940
-21
-2% -$792 ﹤0.01% 4948
2023
Q4 		$39.8K Sell
961
-29
-3% -$927 ﹤0.01% 4994
2023
Q3 		$30.9K Sell
990
-513
-34% -$19.2K ﹤0.01% 5084
2023
Q2 		$69.4K Buy
1,503
+416
+38% +$26K ﹤0.01% 5013
2023
Q1 		$42.4K Buy
1,087
+36
+3% +$2.01K ﹤0.01% 5148
2022
Q4 		$72.8K Buy
1,051
+273
+35% +$15.3K ﹤0.01% 5133
2022
Q3 		$47K Sell
778
-170
-18% -$11.4K ﹤0.01% 5374
2022
Q2 		$65K Buy
948
+404
+74% +$34.2K ﹤0.01% 5359
2022
Q1 		$54K Buy
544
+225
+71% +$25.2K ﹤0.01% 5407
2021
Q4 		$42K Buy
319
+9
+3% +$1.78K ﹤0.01% 5434
2021
Q3 		$64K Buy
+310
New +$77.1K ﹤0.01% 5242

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

BlackRock's INAB Position: Q1 2026 in Review

BlackRock held its IN8bio (INAB) position steady in Q1 2026 at 84 shares worth $124. The position accounts for ﹤0.01% of the portfolio, ranked #5604.

BlackRock first reported a position in INAB in Q3 2021 and has held it in 19 quarters since. The position peaked at $72.8K in Q4 2022. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • BlackRock held 84 shares of IN8bio worth $124 as of Q1 2026.
  • BlackRock left its IN8bio share count unchanged in Q1 2026.
  • IN8bio made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5604 holding.
  • BlackRock first reported a position in IN8bio in Q3 2021 and has held it in 19 quarters since.
  • BlackRock's IN8bio position peaked at $72.8K in Q4 2022.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.